Histone modifications as a platform for cancer therapy
- PMID: 15723344
- DOI: 10.1002/jcb.20387
Histone modifications as a platform for cancer therapy
Abstract
Tumorigenesis and metastasis are a progression of events resulting from alterations in the processing of the genetic information. These alterations result from stable genetic changes (mutations) involving tumor suppressor genes and oncogenes (e.g., ras, BRAF) and potentially reversible epigenetic changes, which are modifications in gene function without a change in the DNA sequence. Mutations of genes coding for proteins that directly or indirectly influence epigenetic processes will alter the cell's gene expression program. Epigenetic mechanisms often altered in cancer cells are DNA methylation and histone modifications (acetylation, methylation, phosphorylation). This article will review the potential of these reversible epigenetic processes as targets for cancer therapies.
Copyright (c) 2005 Wiley-Liss, Inc.
Similar articles
-
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066. J Cell Physiol. 2007. PMID: 17458893 Review.
-
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.Oncogene. 2007 Apr 19;26(18):2621-34. doi: 10.1038/sj.onc.1210041. Epub 2006 Oct 9. Oncogene. 2007. PMID: 17043644
-
Targeting aberrant chromatin structure in colorectal carcinomas.Cancer J. 2007 Jan-Feb;13(1):49-55. doi: 10.1097/PPO.0b013e31803c72fe. Cancer J. 2007. PMID: 17464246 Review.
-
Epigenetic changes in cancer.APMIS. 2007 Oct;115(10):1039-59. doi: 10.1111/j.1600-0463.2007.apm_636.xml.x. APMIS. 2007. PMID: 18042143 Review.
-
Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.Int J Biochem Cell Biol. 2009 Jan;41(1):199-213. doi: 10.1016/j.biocel.2008.08.020. Epub 2008 Aug 22. Int J Biochem Cell Biol. 2009. PMID: 18790076 Review.
Cited by
-
Epigenetic regulation of chromatin structure and gene function by biotin.J Nutr. 2006 Jul;136(7):1763-5. doi: 10.1093/jn/136.7.1763. J Nutr. 2006. PMID: 16772434 Free PMC article. Review.
-
Epigenetics and human disease: translating basic biology into clinical applications.CMAJ. 2006 Jan 31;174(3):341-8. doi: 10.1503/cmaj.050774. CMAJ. 2006. PMID: 16446478 Free PMC article. Review.
-
Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells.J Cancer Res Clin Oncol. 2007 Oct;133(10):725-39. doi: 10.1007/s00432-007-0213-1. Epub 2007 May 4. J Cancer Res Clin Oncol. 2007. PMID: 17487507
-
Chromatin-modifying enzymes as therapeutic targets--Part 1.Expert Opin Ther Targets. 2008 Oct;12(10):1301-12. doi: 10.1517/14728222.12.10.1301. Expert Opin Ther Targets. 2008. PMID: 18781828 Free PMC article. Review.
-
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.Cells. 2019 Oct 8;8(10):1214. doi: 10.3390/cells8101214. Cells. 2019. PMID: 31597272 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
